scispace - formally typeset
A

Annagiulia Gramenzi

Researcher at University of Bologna

Publications -  102
Citations -  3658

Annagiulia Gramenzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Hepatitis C & Liver transplantation. The author has an hindex of 34, co-authored 97 publications receiving 3387 citations. Previous affiliations of Annagiulia Gramenzi include Mario Negri Institute for Pharmacological Research.

Papers
More filters
Journal ArticleDOI

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

TL;DR: Semiannual surveillance increases the detection rate of very early hepatocellular carcinomas and reduces the number of advanced tumors as compared to the annual program, which translates into a greater applicability of effective treatments and into a better prognosis.
Journal ArticleDOI

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e Antigen–negative patients receiving lamivudine therapy

TL;DR: It was found that lamivudine‐resistant mutants were detected at similar rates in patients with HBeAg‐negative as in Patients with H beAg‐positive chronic hepatitis B, suggesting that additional changes in other parts of the HBV genome may restore the replication fitness of lamivUDine‐ resistant mutants.
Journal ArticleDOI

Association between certain foods and risk of acute myocardial infarction in women.

TL;DR: The frequency of consumption of a few simple foods may provide useful indicators of the risk of myocardial infarction and specific foods such as fish, alcohol, or vegetables and fruits may have an independent protective role in therisk of cardiovascular diseases.
Journal ArticleDOI

Review article: alcoholic liver disease--pathophysiological aspects and risk factors.

TL;DR: Alcoholic liver disease has a known aetiology but a complex and incompletely known pathogenesis, but the reason why only a relatively small proportion of heavy drinkers progress to advanced disease remains elusive.